According to Dr Srinivas Kandula, Consultant Endocrinologist at CARE Hospitals, Nampally, Hyderabad, continuous aerobic ...
With the pilot line environment, non-invasive devices enabling early cancer detection and remote heart disease monitoring can advance from re ...
Pharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 million Cash and cash equivalents of $75.7 million as of December 31, 2024 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果